PHARMACY GRADUATE WITH 3 TO 7 YEARS OF EXPERIENCE IN FORMULATION DEVELOPMENT OF STERILE DOSAGE FORMS AS PER GUIDELINES OF US, EU, CANADA, BRAZIL AND ROW MARKET.
First-class PG degree, including integrated PG degree. Candidates with hands-on experience in, Recombinant DNA Technology, Bioprocess Engineering, Metabolic Engineering and Mammalian cell culture-related work will be preferred.
First class Master Degree in any field of Pharmaceutical Sciences. GPAT or equivalent qualification. Experience in ophthalmic formulation development, Polymeric Patch- based drug delivery systems
PG degree from a recognized university in Medical Microbiology/ Microbiology/ Virology/ Zoology/ Parasitological/ Genetics/Medical genetics/ Biotechnology/Genomics/Biochemistry with three years post MSc experience or PhD in relevant fields.
First class M.S. (Pharm.), M. Pharm, M.Tech. (Pharm.) or equivalent degree in Pharmaceutics, Pharmaceutical Technology, Industrial Pharmacy or equivalent branch.
Masters in Pharmaceutical Sciences or Natural or Agricultural. M.Sc. Experience in E. coli biology, biochemistry, cell wall synthesis. Centre for Cellular and Molecular Biology
A PhD in Biological or Chemical Sciences, Life Sciences is essential. postdoctoral experience in the relevant field with at least one research paper in a SCI journal and laboratory experience is desirable.
First Class Post Graduate Degree from a recognized university, including . the integrated PG degree, Proficiency in Biostatistics, Research Methodology and Data analysis
An ability to read and understand diverse literature across the many disciplines relevant to drugs, nucleic acid delivery to distill the best new ideas in the field and apply them to your work. An ability to identify the challenges associated, bottle necks in development and suggest mitigation proposals during development at various stages.
Post Graduate Degree, including the integrated PG degrees, with five years post qualification experience or PhD plus two years post qualification experience.